Dr. Aseel Alsouqi from Ohio State University shared her perspective on the following fixed-duration CLL treatments. Watch her interviews to learn more! 

Venetoclax + Obinutuzumab

Dr. Alsouqi explains in which circumstances CLL patients may consider the fixed-duration combination of venetoclax and obinutuzumab. 

Venetoclax + Rituximab 

Learn when venetoclax and rituximab may be appropriate as your CLL treatment. 

CAR T-cell Therapy Liso-cel

When should you consider receiving liso-cel? Learn from Dr. Alsouqi by watching her interview below.